Association between Intake and Serum Selenium Levels and Risk Factors of Cardiovascular Disease (Narrative Review)

Pahlavani, Naseh; Rostami, Daryoush; Rezaei, Majid; Ferns, Gordon; Ghayour-mobarhan, Majid

doi:10.30483/rijm.2019.118314

Association between Intake and Serum Selenium Levels and Risk Factors of Cardiovascular Disease (Narrative Review)

Authors

¹ Students Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran

² Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

³ Department of Anesthesia, School of Paramedical Sciences, Zabol University of Medical Sciences, Zabol, Iran

⁴ Department of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

⁵ Brighton & Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex BN1 9PH, UK

⁶ Cardiovascular Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

⁷ International UNESCO center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran

10.30483/rijm.2019.118314

Abstract

Background: Selenium (Se) is an essential trace element and is a potent antioxidant that is involved in the activity of several enzymes such as glutathione peroxidase (GPx). Selenium metabolism is associated with the biology of heart and its functions, and selenium deficiency is associated with cardiovascular pathology. Several studies indicate a relationship between selenium and cardiovascular disease.

Objectives: The aim of this study was the investigation of the role of selenium in cardiovascular disease.

Methods: We searched the ISI, PubMed, Scopus, and Google Scholar databases for studies that evaluated the association between selenium levels and cardiovascular health and cardiovascular disease. At first, the studies containing the words "selenium ", "cardiovascular disease", "selenium supplementation", "levels of selenium" and "hypertension" were selected. We searched papers using ‘selenium_, ‘selenium supplementation_, ‘selenium deficiency_and, ‘Se_in combination with ‘cardiovascular disease_, ‘hypertension_’, ‘heart disease_’, ‘heart failure_’ as keywords.

Results: 17 articles (6 randomized clinical trials and 11 observational studies) were eligible to be included in the current review. Some clinical trials have shown that selenium supplementation could reduce the risk of cardiovascular disease including lipid profiles and inflammatory markers. Observational studies showed that low selenium concentrations are a risk factor of cardiovascular disease however, this is not definitive. But the presence of normal levels of selenium is essential for antioxidant defense.

Conclusion: More clinical trial studies with larger sample size are needed to confirm that selenium is effective in preventing and treatment of cardiovascular disease.

Keywords

Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/

References

1. Mendis S, Puska P, Norrving B. Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization; 2011.

2. Gatto L, Marco V, Contarini M, Prati F. Atherosclerosis to predict cardiac events: where and how to look for it. J Cardiovasc Med (Hagerstown). 2017;18(Suppl 1):e154-6. https://doi.org/10.2459/JCM.0000000000000465 PMid:27875346

3. Stadtman TC. Selenoproteins--tracing the role of a trace element in protein function. PLoS Biol. 2005;3(12):e421. https://doi.org/10.1371/journal.pbio.0030421 PMid:16336050 PMCid:PMC1311585

4. Combs GF. Selenium in global food systems. Br J Nutr. 2001;85(5):517-47. https://doi.org/10.1079/BJN2000280 PMid:11348568

5. Mehdi Y, Hornick JL, Istasse L, Dufrasne I. Selenium in the environment, metabolism and involvement in body functions. Molecules. 2013;18(3):3292-311. https://doi.org/10.3390/molecules18033292 PMid:23486107 PMCid:PMC6270138

6. Neve J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk. 1996;3(1):42-7. [PubMed: 8783029]. https://doi.org/10.1177/174182679600300106

7. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. The SU. VI. MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004;164(21):2335-42. https://doi.org/10.1001/archinte.164.21.2335 PMid:15557412

8. Muth O, Oldfield J, Remmert L, Schubert JR. Effects of selenium and vitamin E on white muscle disease. Science. 1958;128(3331):1090. https://doi.org/10.1126/science.128.3331.1090 https://doi.org/10.1126/science.128.3331.1090.a https://doi.org/10.1126/science.128.3331.1090-a

9. Brown KM, Arthur JR. Selenium, selenoproteins and human health: a review. Public Health Nutr. 2001;4(2B):593-9. [PubMed: 11683552]. https://doi.org/10.1079/PHN2001143 PMid:11683552

10. Roemmich JN, Lambiase MJ, Balantekin KN, Feda DM, Dorn J. Stress, behavior, and biology: risk factors for cardiovascular diseases in youth. Exerc Sport Sci Rev. 2014;42(4):145-52. https://doi.org/10.1249/JES.0000000000000027 PMid:25061998 PMCid:PMC6459183

11. Vasconcellos F, Seabra A, Katzmarzyk PT, Kraemer-Aguiar LG, Bouskela E, Farinatti P. Physical activity in overweight and obese adolescents: systematic reviewof the effectsonphysical fitness components and cardiovascular risk factors. Sports Med. 2014;44(8):1139-52. https://doi.org/10.1007/s40279-014-0193-7 PMid:24743931

12. Ji F, Ning F, Duan H, Kaprio J, Zhang D, Zhang D, et al. Genetic and environmental influences on cardiovascular disease risk factors: a study of Chinese twin children and adolescents. Twin Res Hum Genet. 2014;17(2):72-9. https://doi.org/10.1017/thg.2014.5 PMid:24576535

13. D'Addato S, Palmisano S, Borghi C. How important are triglycerides as risk factors? J Cardiovasc Med. 2017;18(Suppl 1):e7-12. https://doi.org/10.2459/JCM.0000000000000438 PMid:27763943

14. Shils ME, Shike M. Modern nutrition in health and disease. Philadelphia: Lippincott Williams & Wilkins; 2006.

15. Benstoem C, Goetzenich A, Kraemer S, Borosch S, Manzanares W, Hardy G, et al. Selenium and its supplementation in cardiovascular disease--what do we know? Nutrients. 2015;7(5):3094-118. https://doi.org/10.3390/nu7053094 PMid:25923656 PMCid:PMC4446741

16. Maulik N, Das DK. Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions. Biochim Biophys Acta. 2008;1780(11):1368-82. https://doi.org/10.1016/j.bbagen.2007.12.008 PMid:18206121

17. Lu C, Qiu F, Zhou H, Peng Y, Hao W, Xu J, et al. Identification and characterization of selenoprotein K: an antioxidant in cardiomyocytes. FEBS Lett. 2006;580(22):5189-97. https://doi.org/10.1016/j.febslet.2006.08.065 PMid:16962588

18. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr. 2006;84(4):762-73. https://doi.org/10.1093/ajcn/84.4.762 PMid:17023702 PMCid:PMC1829306

19. Loscalzo J. Keshan disease, selenium deficiency, and the selenoproteome. N Engl J Med. 2014;370(18):1756-60. https://doi.org/10.1056/NEJMcibr1402199 PMid:24785212

20. Omrani H, Golmohamadi S, Pasdar Y, Jasemi K, Almasi A. Effect of selenium supplementation on lipid profile in hemodialysis patients. J Renal Inj Prev. 2016;5(4):179-82. https://doi.org/10.15171/jrip.2016.38 PMid:27689119 PMCid:PMC5039985

21. Boskabadi H, Maamouri G, Rezagholizade Omran F, Mafinejad S, Tara F, Rayman MP, et al. Effect of prenatal selenium supplementation on cord blood selenium and lipid profile. Pediatr Neonatol. 2012;53(6):334-9. https://doi.org/10.1016/j.pedneo.2012.08.008 PMid:23276436

22. Stranges S, Marshall JR, Trevisan M, Natarajan R, Donahue RP, Combs GF, et al. Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol. 2006;163(8):694-9. https://doi.org/10.1093/aje/kwj097 PMid:16495471

23. Rees K, Hartley L, Day C, Flowers N, Clarke A, Stranges S. Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1:CD009671. https://doi.org/10.1002/14651858.CD009671.pub2

24. Joseph J, Loscalzo J. Selenistasis: epistatic effects of selenium on cardiovascular phenotype. Nutrients. 2013;5(2):340-58. https://doi.org/10.3390/nu5020340 PMid:23434902 PMCid:PMC3635198

25. Satia JA, King IB, Morris JS, Stratton K, White E. Toenail and plasma levels as biomarkers of selenium exposure. Ann Epidemiol. 2006;16(1):53-8. https://doi.org/10.1016/j.annepidem.2005.02.011 PMid:15961316

26. Longnecker MP, Stram DO, Taylor PR, Levander OA, Howe M, Veillon C, et al. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology. 1996;7(4):384-90. https://doi.org/10.1097/00001648-199607000-00008 PMid:8793364

27. Salonen J, Alfthan G, Huttunen J, Pikkarainen J, Puska P. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet. 1982;2(8291):175-9. https://doi.org/10.1016/S0140-6736(82)91028-5 PMid:6123886

28. Parizadeh SM, Moohebati M, Ghafoori F, Ghayour-Mobarhan M, Kazemi-Bajestani SM, Tavallaie S, et al. Serum selenium and glutathione peroxidase concentrations in Iranian patients with angiography-defined coronary artery disease. Angiology. 2009;60(2):186-91. https://doi.org/10.1177/0003319708319780 PMid:18586758

29. Parizadeh SM, Moohebati M, Ghafoori F, Ghayour-Mobarhan M, Kazemi-Bajestani SM, Tavallaie S, et al. Serum selenium and glutathione peroxidase concentrations in Iranian patients with angiography-defined coronary artery disease. Angiology. 2009;60(2):186-91. https://doi.org/10.1177/0003319708319780 PMid:18586758

30. González-Estecha M, Palazón-Bru I, Bodas-Pinedo A, Trasobares E, Palazón-Bru A, Fuentes M, et al. Relationship between serum selenium, sociodemographic variables, other trace elements and lipid profile in an adult Spanish population. J Trace Elem Med Biol. 2017;43:93-105. https://doi.org/10.1016/j.jtemb.2016.12.002 PMid:28073603

31. Stranges S, Navas-Acien A, Rayman MP, Guallar E. Selenium status and cardiometabolic health: state of the evidence. Nutr Metab Cardiovasc Dis. 2010;20(10):754-60. https://doi.org/10.1016/j.numecd.2010.10.001 PMid:21094028

32. Ghayour-Mobarhan M, Taylor A, Lanham-New S, Lamb DJ, Nezhad MA, Kazemi-Bajestani SM, et al. Serum selenium and glutathione peroxidase in patients with obesity and metabolic syndrome. Pak J Nutr. 2008;7(1):112-7. https://doi.org/10.3923/pjn.2008.112.117

33. Laclaustra M, Navas-Acien A, Stranges S, Ordovas JM, Guallar E. Serum selenium concentrations and hypertension in the US population. Circ Cardiovasc Qual Outcomes. 2009;2(4): 369- 76. https://doi.org/10.1161/CIRCOUTCOMES.108.831552 PMid:20031863 PMCid:PMC2773506

34. Nawrot TS, Staessen JA, Roels HA, Den Hond E, Thijs L, Fagard RH, et al. Blood pressure and blood selenium: a cross-sectional and longitudinal population study. Eur Heart J. 2007; 28(5):628-33. https://doi.org/10.1093/eurheartj/ehl479 PMid:17242009

35. Beck MA, Kolbeck PC, Rohr LH, Shi Q, Morris VC, Levander OA. Benign human enterovirus becomes virulent in selenium‐deficient mice. J Med Virol. 1994;43(2):166-70. https://doi.org/10.1002/jmv.1890430213 PMid:8083665

36. Beck MA. Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency. J Nutr. 1997;127(5):966S- 70S. https://doi.org/10.1093/jn/127.5.966S PMid:9164275

37. Stranges S, Sieri S, Vinceti M, Grioni S, Guallar E, Laclaustra M, et al. A prospective study of dietary selenium intake and risk of type 2 diabetes. BMC Public Health. 2010;10:564. https://doi.org/10.1186/1471-2458-10-564 PMid:20858268 PMCid:PMC2949772

38. Laclaustra M, Stranges S, Navas-Acien A, Ordovas JM, Guallar E. Serum selenium and serum lipids in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Atherosclerosis. 2010;210(2):643-8. https://doi.org/10.1016/j.atherosclerosis.2010.01.005 PMid:20102763 PMCid:PMC2878899

39. Alamdari DH, Ghayour-Mobarhan M, Tavallaie S, Parizadeh MR, Moohebati M, Ghafoori F, et al. Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease. Clin Biochem. 2008;41(6):375-80. https://doi.org/10.1016/j.clinbiochem.2007.12.008 PMid:18191639

40. Landmesser U, Harrison DG. Oxidant stress as a marker for cardiovascular events: Ox marks the spot. Circulation. 2001;104(22):2638-40. [PubMed: 11723010]. https://doi.org/10.1161/circ.104.22.2638 PMid:11723010

41. Motamed S, Ebrahimi M, Safarian M, Ghayour-Mobarhan M, Mouhebati M, Azarpazhouh M, et al. Micronutrient intake and the presence of the metabolic syndrome. N Am J Med Sci. 2013;5(6):377-85. https://doi.org/10.4103/1947-2714.114171 PMid:23923113 PMCid:PMC3731870

42. Rayman MP. The importance of selenium to human health. Lancet. 2000;356(9225):233-41. https://doi.org/10.1016/S0140-6736(00)02490-9 PMid:10963212

43. Alehagen U, Aaseth J. Selenium and coenzyme Q10 interrelationship in cardiovascular diseases-A clinician's point of view. J Trace Elem Med Biol. 2015;31:157-62 https://doi.org/10.1016/j.jtemb.2014.11.006 PMid:25511910

44. Asemi Z, Jamilian M, Mesdaghinia E, Esmaillzadeh A. Effects of selenium supplementation on glucose homeostasis, inflammation, and oxidative stress in gestational diabetes: Randomized, double-blind, placebo-controlled trial. Nutrition. 2015;31(10):1235-42. https://doi.org/10.1016/j.nut.2015.04.014 PMid:26250486

45. Bahmani F, Kia M, Soleimani A, Mohammadi AA, Asemi Z. The effects of selenium supplementation on biomarkers of inflammation and oxidative stress in patients with diabetic nephropathy: a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2016;116(7):1222-8. https://doi.org/10.1017/S0007114516003251 PMid:27647263

46. Lymbury RS, Marino MJ, Perkins AV. Effect of dietary selenium on the progression of heart failure in the ageing spontaneously hypertensive rat. Mol Nutr Food Res. 2010;54(10):1436-44. https://doi.org/10.1002/mnfr.201000012 PMid:20486210

47. Traulsen H, Steinbrenner H, Buchczyk DP, Klotz LO, Sies H. Selenoprotein P protects low-density lipoprotein against oxidation. Free Radic Res. 2004;38(2):123-8. https://doi.org/10.1080/10715760320001634852 PMid:15104205

48. Omrani HR, Rahimi M, Nikseresht K. The effect of selenium supplementation on acute phase reactants and thyroid function tests in hemodialysis patients. Nephrourol Mon. 2015;7(2):e24781. https://doi.org/10.5812/numonthly.24781 PMid:25883912 PMCid:PMC4393550

49. Alehagen U, Johansson P, Björnstedt M, Rosén A, Dahlström U. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo- controlled trial among elderly Swedish citizens. Int J Cardiol. 2013;167(5):1860-6. https://doi.org/10.1016/j.ijcard.2012.04.156 PMid:22626835

50. Mao J, Bath SC, Vanderlelie JJ, Perkins AV, Redman CW, Rayman MP. No effect of modest selenium supplementation on insulin resistance in UK pregnant women, as assessed by plasma adiponectin concentration. Br J Nutr. 2016;115(1):32- 8. https://doi.org/10.1017/S0007114515004067 PMid:26481811

Razavi International Journal of Medicine

Article View: 331
PDF Download: 244

Association between Intake and Serum Selenium Levels and Risk Factors of Cardiovascular Disease (Narrative Review)

References

Volume 7, Issue 2
April 2019
Pages 4-11

Files

Share

How to cite

Statistics

Association between Intake and Serum Selenium Levels and Risk Factors of Cardiovascular Disease (Narrative Review)

References

Volume 7, Issue 2April 2019Pages 4-11

Files

Share

How to cite

Statistics

Volume 7, Issue 2
April 2019
Pages 4-11